Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults

Annals of Medicine

Volumn 45, Issue 1, 2013, Pages 37-50

  Alagiakrishnan, Kannayiram ^a   Banach, MacIej ^b   Jones, Linda G ^c,d   Datta, Subrata ^a   Ahmed, Ali ^c,d   Aronow, Wilbert S ^e  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Chronic baroreflex activation; Chronotropic incompetence; Diastolic heart failure; Gene therapy; Heart failure with preserved ejection fraction; Older adults

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CANDESARTAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; GROWTH DIFFERENTIATION FACTOR 15; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; IRBESARTAN; NEBIVOLOL; NORADRENALIN; PENTRAXIN 3; PERINDOPRIL; PREALBUMIN; PROPRANOLOL; RAMIPRIL; RIBOSE; SPIRONOLACTONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VITAMIN D;

ANEMIA; ANOREXIA; ANXIETY DISORDER; BLOATING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGRAPHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CHEMORECEPTOR REFLEX; CONFUSION; CORONARY ARTERY DISEASE; DEVICE THERAPY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ELECTROCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; ETHNICITY; EXERCISE; FATIGUE; GENE THERAPY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEART ATRIUM FIBRILLATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTPUT; HEART PALPITATION; HEART RATE; HEART STROKE VOLUME; HEPATOMEGALY; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; KIDNEY FAILURE; LUNG EDEMA; MEMORY DISORDER; META ANALYSIS (TOPIC); NAUSEA; NOCTURIA; OBESITY; OLIGURIA; PATHOPHYSIOLOGY; PATIENT EDUCATION; PERIPHERAL EDEMA; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTRICTIVE CARDIOMYOPATHY; REVIEW; SEPSIS; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; SYSTOLIC HEART FAILURE; TACHYCARDIA; THORAX PAIN; THORAX RADIOGRAPHY; WEAKNESS;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; BIOMARKERS, PHARMACOLOGICAL; CARDIAC RESYNCHRONIZATION THERAPY; DIURETICS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENETIC THERAPY; HEART FAILURE, DIASTOLIC; HUMANS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84865463493     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2012.660493     Document Type: Review

References (186)

1. Baicu CF, Zile MR, Aurigemma GP, 1. Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation. 2005;111:2306-12. (Pubitemid 40647065)
2. Ennezat PV, Lefetz Y, Marechaux S, et al. Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail. 2008;14:475-80.
3. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al.; ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-442.
4. Hunt SA, Abraham WT, Chin MH, et a l. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-235.
5. Rosamond W, Flegal K, Friday G, et a l. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-171.
6. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007-18.
7. Lloyd-Jones DM, Larson MG, Leip EP, et a l. Life-time risk for developing congestive heart failure: The Framingham Study. Circulation. 2002;106:3068-72. (Pubitemid 35440290)
8. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: Prevalence, incidence rate, lifetime risk and prognosis of heart failure. Th e Rotterdam Study. Eur Heart J. 2004;25:1614-9. (Pubitemid 39209281)
9. Aurigemma GP, Zile MR, Gaasch WH. Contractile behavior of the left ventricle in diastolic heart failure: With emphasis on regional systolic function. Circulation. 2006;113:286-304.
10. Kitzman DW, Sheikh KH, Beere PA, et a l. Age-related alterations of Doppler left ventricular fi lling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol. 1991;18:1243.
11. Hunt SA, Abraham WT, Chin MH, et al. Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119: E391-479.
12. Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments and outcomes of patients with preserved systolic function hospitalized for heart failure. A report from the Optimize HF registry. J Am Coll Cardiol. 2007;50:768-77. (Pubitemid 47243795)
13. Ceia F, Fonseca C, Mota T, et a l. Prevalence of chronic heart failure in Southwestern Europe: The EPICA study. Eur J Heart Fail. 2002;4:531-9. (Pubitemid 36564974)
14. Owan TE, Hodge DO, Davie AP, et a l. Epidemiology of chronic heart failure. Prog Cardiovasc Dis. 2005;47:320-32.
15. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function: Epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317-27. (Pubitemid 38167688)
16. Aronow WS, Ahn C, Kronzon I. Comparison of incidence of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol. 1999;84:611-2. (Pubitemid 29408601)
17. Sharp A, Tapp R, Francis DP, et al. Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. J Am Coll Cardiol. 2008;52:1015-21.
18. East MA, Peterson ED, Shaw LK, et al. Racial diff erence in the outcomes of patients with diastolic heart failure. Am Heart J. 2004; 148:151-6. (Pubitemid 38900495)
19. Newton JB, Blackledge HM, Squire IB. Ethnicity and variation in prognosis for patients newly hospitalized for heart failure. A matched historical cohort study. Heart. 2003;91:1545-50.
20. Nancy CW. Th e prevention of heart failure in minority communities and discrepancies in healthcare delivery systems. Med Clin N Am. 2004;88:1347-68.
21. Andrew P. Diastolic heart failure demystified. Chest. 2003;124: 744-53. (Pubitemid 37000159)
22. Gandhi SK, Powers JC, Nomeir AM, et a l. Th e pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17-22. (Pubitemid 32064840)
23. Kitzman DW, Little WC, Brubaker PH, et a l. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure JAMA. 2002;288:2144-50. (Pubitemid 35265382)
24. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiff ness of the left ventricle N Engl J Med. 2004;350:1953- 9.
25. Oxenham HC, Young AA, Cowan BR, et a l. Age related changes in myocardial relaxation using three dimensional tagged magnetic resonance imaging. J Cardiovasc Magn Reson. 2003;5:421-30. (Pubitemid 36859425)
26. van Heerebeek L, Borbely A, Niessen HW, et a l. Myocardial function and structure diff er in systolic and diastolic heart failure. Circulation. 2006;113:1966-73.
27. Zile MR, Brutsaert DL. New concepts of diastolic dysfunction and diastolic heart failure: Diagnosis, prognosis, and measurement of diastolic function. Circulation. 2002;105:1387-93. (Pubitemid 34260433)
28. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849-65.
29. Rapp JA, Gheorghiade M. Role of neurohormonal modulators in heart failure with relatively preserved systolic function. Cardiol Clin. 2008;26:23-40. (Pubitemid 351288515)
30. Wang J, Kurrelmeyer KM, Torre-Amione N, Nagueh SF. Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the eff ect of medical therapy. J Am Coll Cardiol. 2007;49:88-96. (Pubitemid 46026901)
31. Lam CS, Roger VL, Rodeheff er R, et a l. Cardiac structure and ventri cular-vascular function in persons with heart failure and preserved ejection fraction: From Olmsted county, Minnesota. Circulation. 2007;115:1982-90. (Pubitemid 46625948)
32. Borlaug BA, Kass KA. Ventricular-vascular interaction in heart failure. Heart Fail Clin. 2008;4:23-36. (Pubitemid 351289326)
33. Orso F, Baldasseroni S, Maggioni A. Heart rate in coronary syndromes and heart failure. Prog Cardiovasc Dis. 2009;32:38-43.
34. Phan TT, Shivu GN, Abozuia K, et a l. Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail. 2010;3:29-34.
35. Borlaug BA, Olson TP, Lam CS, et a l. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56:845- 54.
36. Vinereanu D, Nicolaides E, Tweddel AC, Fraser AG. Pure diastolic dysfunction is associated with long-axis systolic dysfunction: implications for the diagnosis and classifi cation of heart failure. Eur J Heart Fail. 2005;7:820-8. (Pubitemid 41125900)
37. Garcia EH, Perna ER, Farias EF, et al. Reduced systolic performance by tissue Doppler in patients with preserved and abnormal ejection fraction: New insights in chronic heart failure. Int J Cardiol. 2006;108:181-8. (Pubitemid 43330611)
38. Tan YT, Wenzelburger F, Le H, et al. Exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist and longitudinal motion. J Am Coll Cardiol. 2009;54:36- 46.
39. Jorge AJL, Silva EN, Fernandes LC, et a l. Evaluation of longitudinal systolic function in heart failure with normal ejection fraction. Arq Bras Cardiol. 2010;94:799- 805.
40. Chen HH, Lainchbury JG, Senni M, et a l. Diastolic heart failure in the community: Underlying cardiovascular diseases and precipitative factors. Circulation. 2000;102:771- 80.
41. Jacobson DR, Passore RD, Yaghoubian R, et a l. Variant-sequence transthyretin (Isoleucine 122) in late-onset cardiac amyloidosis in Black Americans. N Engl J Med. 1999;356:466-73. (Pubitemid 27074357)
42. Falk RH. Diagnosis and management of the cardiac amyloidosis. Circulation. 2005;112:2047-60.
43. McMurray JJ, Carson PE, Komajda M, et a l. Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trail. Eur J Heart Fail. 2008;10149-56.
44. Szidon JP. Pathophysiology of the congested lung. Cardiol Clin. 1989;7:39-48. (Pubitemid 19070272)
45. Chen HH, Luinchbury JG, Senni M, et a l. Diastolic heart failure in the community: Clinical profi le, natural history, therapy and impact of proposed diagnostic criteria. J Card Fail. 2002;8:279-87. (Pubitemid 35253198)
46. Fung JW, Sanderson JE, Yip GW, et a l. Impact of atrial fi brillation in heart failure with normal ejection fraction: A clinical and echocardiographic study. J Card Fail. 2007;13:649-55. (Pubitemid 47516702)
47. Tsang TS, Gersh BJ, Appleton CP, et al. Left ventricular diastolic dysfunction as a predictor of fi rst diagnosed non valvular atrial fi brillation in 840 elderly men and women. J Am Coll Cardiol. 2002;40:1636-44. (Pubitemid 35253642)
48. Ahmed A, Zile MR, Rich MW, et a l. Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure. Am J Cardiol. 2007;99:460-4. (Pubitemid 46215547)
49. Tresch DD. Atypical presentation of cardiovascular disorders in the elderly. Geriatrics. 1987;42:41- 6.
50. Zuccala G, Cattel C, Manes-Gravina E, et al. Left ventricular dysfunction: A clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry. 1997;63:509-12. (Pubitemid 27423561)
51. Davie AP, Francis CM, Caruana L,et al. Assessing diagnosis in heart failure: Which features are of any use? QJM. 1997;90:335-9. (Pubitemid 27237032)
52. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary heart care. Eur Heart J. 1991;12:315-21.
53. Ahmed A. DEFEAT-Heart failure: A guide to management of geriatric heart failure by generalist physicians. Minerva Med. 2009;100:39-50.
54. Stevenson LW, Perloff JK. Th e limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884-8. (Pubitemid 19046417)
55. Lien CTC, Gillespie ND, Struthers AD, McMurdo MET. Heart failure in frail elderly patients: Diagnostic diffi culties, co-morbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail. 2002;4:91-8. (Pubitemid 34113333)
56. Oudejans I, Mosterd A, Bluemen JA, et a l. Clinical evaluation of geriatric outpatients with suspected heart failure: Value of symptoms, signs and additional tests. Eur J Heart Fail. 2011;13:518-27.
57. Rich MW. Offi ce management of heart failure in the elderly. Am J Med. 2005;118:342-48. (Pubitemid 40467522)
58. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part II: Causal mechanisms and treatment. Circulation. 2002;105:1503-8. (Pubitemid 34263285)
59. Erne P. Beyond auscultation-a coustic cardiography in the diagnosis and assessment of cardiac disease. Swiss Med Wkly. 2008;138:439-52.
60. Dillier R, Zuber M, Arand P, et al. Assessment of systolic and diastolic function in asymptomatic subjects using ambulatory monitoring with acoustic cardiography. Clin Cardiol. 2011;34:384-8.
61. Dargie HJ, McMurray JJ. Diagnosis and management of heart failure. BMJ. 1994;308:321-8. (Pubitemid 24084146)
62. Galinier M, Vialette JC, Fourcade J, et al. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Eur Heart J. 1998;19:1054-62. (Pubitemid 28321386)
63. Zareba KM, Shenkman HJ, Bibognano JD. Predictive value of admission electrocardiography in patients with heart failure. Congest Heart Fail. 2008;4:173-9.
64. Baldasteroni S, Gentile A, Gorini M, et al. Intraventricular conduction defects in patients with congestive heart failure: Left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian network on congestive heart failure (In-CHF database). Ital Heart J. 2003;4:607-13.
65. Anderson JL, Askins JC, Gilbert EM, Menlove RL, Lutz Jr. Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of Milrinone. Am Heart J. 1986;111:466-74. (Pubitemid 16130121)
66. Tisdale JE, Patel R, Webb CR, et al. Electrophysiologic and proarr hythmic eff ects of intravenous inotropic agents. Prog Cardiovasc Dis. 1995;38:167-180.
67. Burger AJ, Elkayam U, Neibaur MT, et a l. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol. 2001;88:35-9. (Pubitemid 32553889)
68. Guidelines for the diagnosis of heart failure. Th e Task Force of the European Society of Cardiology. Eur Heart J. 1995;16:741-51.
69. Mattu A, Martinez JP, Kelly BS. Modern management of cardiogenic pulmonary edema. Emerg Med Clin North Am. 2005;23:1105-25. (Pubitemid 41400102)
70. Hunt S, Baker D, Chin M, et a l. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary report of the American College of cardiology/ American Heart association Task Force on Practice Guidelines. Circulation. 2001; 104:2996.
71. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005). Eur Heart J. 2005;26:1115-40.
72. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiography. 2009;22:107-33.
73. Murata K. Predictive signifi cance of evaluation of left ventricular diastolic function in patients with heart failure. Rinsho Byoki. 2010;58:792-8.
74. Masutani S, Little WC, Hasegawah, et al. Restrictive left ventricular fi lling pattern does not result from increased left atrial pressure alone. Circulation. 2008;117:1550-54. (Pubitemid 351440644)
75. Yip G, Wang M, Fung JWH, et al. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: Time for a redefi nition? Heart. 2002;87:121-5. (Pubitemid 34098370)
76. Yip GWK, Zhang G, Xie JM, et a l. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: Insights from speckle-tracking echocardiography. Heart. 2011;97:287-94.
77. Bruch C, Gradaus R, Guinia S, et al. Doppler tissue analysis of mitral annular velocities: Evidence for systolic abnormalities in patients with diastolic heart failure. J Am Soc Echocardiography. 2003;16:1031-6. (Pubitemid 37210929)
78. Ohtani T, Yamamoto K, Dunlay SM, et a l. Severity of LV diastolic stiff-ness as assessed by the diastolic wall strain index is associated with worse outcomes in heart failure with preserved ejection fraction. Circulation. 2010;122:A12731.
79. McMannus DD, Shah SI, Fabi MR, et al. Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: Data from the heart and soul study. J Am Soc Echocardiogr. 2009;22:190-7.
80. Assoumull RG, Penell DJ, Prasad SK. Cardiovascular magnetic resonance in the evaluation of heart failure. Heart. 2007;93:985-92. (Pubitemid 47122058)
81. Caudron J, Fares J, Bauer F, et a l. Evaluation of left ventricular diastolic function with cardiac MR imaging. Radiographics. 2011;31: 239-59.
82. Kedar J, Tarun P. Evaluation of diastolic dysfunction using cardiac magnetic resonance imaging. European Cardiology. 2010;6:21-5.
83. Gori CS, Magrini L, Travalino F. Di Somma S. Role of biomarkers in patients with dyspnea. Eur Rev Med Pharmacol Sci. 2011; 15:229-40.
84. Maisel AS, McCord J, Nowak RM, et al. Bedside B type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol. 2003;41:2010-7. (Pubitemid 36677124)
85. McKie PM, Burnett JC. B-type natriureteric peptide as a biomarker beyond heart failure, speculations and opportunities. Mayo Clin Proc. 2005:80:1029-36. (Pubitemid 41099389)
86. Cleland JG, Taylor J, Tendera M. Prognosis in heart failure with a normal ejection fraction. N Engl J Med. 2007;357:829-30. (Pubitemid 47295663)
87. Stahrenberg R, Edelman F, Mende M, et a l. Th e novel biomarker growth diff erentiation factor 15 in heart failure with normal ejection fraction. Eur J Heart Fail. 2010;12:1309-16.
88. Heymans S, Schrien B, Verneersch P, et a l. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fi brosis and dysfunction in the chronic pressure overloaded human heart. Circulation. 2005;112: 1136-44. (Pubitemid 41216120)
89. Gonzalez A, Lopez B, Querejeta R, et a l. Filling pressure and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction. Hypertension. 2010;55:1418-24.
90. Matsubara J, Sugiyama S, Nozaki T, et a l. Pentraxin 3 is a new infl ammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction. J Am Coll Cardiol. 2011;57:861-9.
91. Kume N, Mitsuoka H, Hayashida K, Tanaka M. Pentraxin 3 as a biomarker for acute coronary syndrome. Comparison with biomarkers for cardiac damage. J Cardiol. 2011;58:38-45.
92. Fonseca C, Morais H, Mota T, et a l. Th e diagnosis of heart failure in primary care: Value of symptoms and signs. Eur J Heart Fail. 2004;6:795-800. (Pubitemid 39470237)
93. Paulus WJ, Tschope C, Sanderson JE, et a l. How to diagnose diastolic heart failure: A consensus statement for the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Association of the European Society Cardiology. Eur Heart J. 2007;28:2539-50. (Pubitemid 47614269)
94. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure aft er prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction. Am J Cardiol. 2000;85:1382-4. (Pubitemid 30314679)
95. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: Infl uence of left ventricular systolic function. Th e Cardiovascular Health Study. Ann Intern Med. 2002;137:631-9. (Pubitemid 35176095)
96. O' Connor CM, Gattis WA, Shaw L, et al. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol. 2000;86:863-7.
97. McAlister FA, Teo KK, Taher M, et a l. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J. 1999;138:87-94. (Pubitemid 29331126)
98. Brucks S, Little WC, Chao T, et al. Relation of anemia to diastolic heart failure and the eff ect on outcome. Am J Cardiol. 2004;93:1055-7. (Pubitemid 38479469)
99. Ahmed MI, Lainscak M, Mujib M, et al. Gender-related dissociation in outcomes in chronic heart failure: Reduced mortality but similar hospitalization in women. Int J Cardiol. 2011;148:36-42.
100. Nguyen PK, Schmittger I, Heidenreich PA. A comparison of echocardiographic measures of diastolic function for predicting all-cause mortality in a predominantly male population. Am Heart J. 2011;161:530-4.
101. Borlaug BA, Lam CS, Roger VL, et al. Contactility and ventricular systolic stiff ening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol. 2009;54:410- 8.
102. Bella JN, Palmieri V, Roman MJ, et al. Mitral ratio of peak early to late diastolic fi lling velocity as a predictor of mortality in middle-aged and elderly adults: The Strong Heart Study. Circulation. 2002;105:1928-33. (Pubitemid 34437620)
103. Ren X, Ristow B, Na B, et a l. Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease. Am J Cardiol. 2007;99:1643-7. (Pubitemid 46876725)
104. Kumar R, Gandhi SK, Little WC. Acute heart failure with preserved systolic function. Crit Care Med. 2008;36(suppl):S52-6.
105. Aurigemma GP, Gaasch WH. Diastolic heart failure. N Engl J Med. 2004;351:1097-2005.
106. Sica DA, Gehr TWB, Frishman WH. Use of diuretics in the treatment of heart failure in the elderly. Clin Geriatr Med. 2007;23:107-21.
107. Yip GWK, Wang M, Wang T, et al. Th e Hong Kong diastolic heart failure study: A randomized controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection. Heart. 2008;94:573-80. (Pubitemid 351580128)
108. Roongsritong C, Sutthiwan P, Bradley J, et a l. Sprinolactone improves diastolic function in the elderly. Clin Cardiol. 2005;28:484-7. (Pubitemid 41434276)
109. Beckett NS, Peters R, Fletcher AE, et a l.; HYVET study group. Treatment of hypertension in patients 80 years of age or older. N Eng J Med. 2008;358:1887-98. (Pubitemid 351620109)
110. Martinez FA. Aldosterone inhibition and cardiovascular protection: More important than it once appeared. Cardiovasc Drug Th er. 2010;24:345-50.
111. Shapiro W. Correlative studies of serum digitalis levels and the arrhythmias of digitalis intoxication. Am J Cardiol. 1978;41:852-9. (Pubitemid 8327724)
112. Aronow WS, Kronzon I. Eff ect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol. 1993;71:602-4. (Pubitemid 23065018)
113. Massie BM, Carson PE, Mcmurray JJ, et a l. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456-67.
114. Yusuf S, Pfeff er MA, Swedberg K, et al. Eff ects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: The CHARM Preserved Trial. Lancet. 2003;362:777-81. (Pubitemid 37093918)
115. Cleland JG, Tendera M, Adamus J, et al. Th e perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27:2338-45. (Pubitemid 44453578)
116. Klingbeil AU, Schneider M, Martus P, et a l. A meta-analysis of the eff ects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115:41-6. (Pubitemid 36831120)
117. Aronow WS, Ahn C, Kronzon I. Eff ect of propanolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction - 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am J Cardiol. 1997;80:207-9. (Pubitemid 27329224)
118. Ghio S, Magrini G, Serio A, et a l. Eff ects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: Results of the Seniors echocardiographic substudy. Eur Heart J. 2006;27:562-8.
119. Setaro JF, Zaret BL, Schulman DS, Black HR, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic fi lling and normal left ventricular systolic performance. Am J Cardiol. 1990;66:981-6. (Pubitemid 20360593)
120. Frenneaux M, Willims L. Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic fi lling. Prog Cardiovasc Dis. 2007;49:252- 62. (Pubitemid 44918058)
121. Solomon SD, Janardhanan R, Verma A, et al. Eff ect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomized trial. Lancet. 2007;369:2079-87. (Pubitemid 46935945)
122. Holland DJ, Kumbhani DJ, Ahmed SH, Marwick TH. Eff ects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction, a meta-analysis. J Am Coll Cardiol. 2011;57:1676- 86.
123. Banach M, Bhatia V, Feller MA, et al. Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. Am J Cardiol. 2011;107:1208-14.
124. Ahmed A, Rich MW, Fleg JL, et al. Eff ects of digoxin on morbidity and mortality in diastolic heart failure; the ancillary digitalis investigation group trial. Circulation. 2006;114:266-70.
125. Fukuta H, Same DC, Brucks S, Little WC, et al. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: A preliminary report. Circulation. 2005;112:357-63. (Pubitemid 41022076)
126. Shah R, Wang Y, Foody JM. Eff ects of statin, angiotensin-converting enzyme inhibitors and beta blockers on survival in patients - 65 years of age with heart failure and preserved left ventricular systolic function. Am J Cardiol. 2008;2:217-22.
127. Tehrani F, Morrissey R, Phan A, et al. Statin therapy in patients with diastolic heart failure. Clin Cardiol. 2010;35:e1-5.
128. Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J. Time for new indications for statins? Med Sci Monit. 2009;15:MS1-5.
129. Omran H, Illien S, MacCarter D, et a l. D-ribose improves diastolic function and quality of life in congestive heart failure patients: A prospective feasibility study. Eur J Heart Fail. 2003;5:615-9. (Pubitemid 38043966)
130. MacCarter D, Vijay N, Washam M, et al. D-ribose aids. Advanced ischemic heart failure patients. Int J Cardiol. 2009;137:79-80.
131. Cruickshank JM. Beta blockers and heart failure. Indian Heart J. 2010;62:101-10.
132. Banerjee P, Banerjee T, Khand A, et a l. Diastolic heart failure: Neglected or misdiagnosed. J Am Coll Cardiol. 2002;39:138-41. (Pubitemid 34059873)
133. Brenner DA, Apstein CS, Saupe KW. Exercise training attenuates age-associated diastolic dysfunction in rats. Circulation. 2001; 104:221-6. (Pubitemid 32655842)
134. Takemoto KA, Bernstein L, Lopez JF, et a l. Abnormalities of diastolic fi lling of the left ventricle associated with aging are less pronounced in exercise-trained individuals. Am Heart J. 1992;124:143-8.
135. Waggoner AD, Faddis MN, Gleva MJ, et a l. Cardiac resynchronization therapy acutely improves diastolic function. J Am Soc Echocardiogr. 2005;18:216-20. (Pubitemid 40289040)
136. Georgegaropoulos D, Little CW, Abraham WT, et a l. Chronic barorefl ex activation: A potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail. 2011;17:167-78.
137. Wu CK, Tsai CT, Chang YC, et al. Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure. J Hypertens. 2009;27:502-7.
138. Cappola T. Molecular remodeling in human heart failure. J Am Coll Cardiol. 2008;15:137- 8.
139. Arai M, Alpert N R, MacLennan D H, et al. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-9. (Pubitemid 23024533)
140. Chaudhri B, del Monte F, Harding S, et a l. Gene transfer in cardiac myocytes. Surg Clin North Am. 2004;84:141-9.
141. Rostland SG, Drueke TB. Parathyroid hormone, vitamin D and cardiovascular disease in chronic renal failure. Kidney Int. 1999;56:383-92. (Pubitemid 29353135)
142. Tishkoff DX, Nibbelink KA, Holmberg KH, et a l. Function vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology. 2008;149:558-64. (Pubitemid 351159356)
143. Green II, Robinson DA, Wilson GE, et al. Calcitriol modulation of cardiac contractile performance via protein kinase C. J Mol Cell Cardiol. 2006;41:350- 9. (Pubitemid 44088655)
144. Cheng T, Gardner DG. 1,25(OH) 2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest. 1996;97:1577-88. (Pubitemid 26105467)
145. Nigwekar SU, Bhan I, Th adhani R. Vitamin D, hypertension, left ventricular hypertrophy, and diastolic dysfunction. Curr Cardiovasc Risk Rep. 2011:1- 9.
146. Javaheri S, Parker TJ, Lining D, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalence, consequences and presentations. Circulation. 1998;97:2154-9. (Pubitemid 28262123)
147. Somers VK, Dyken M, Clary MS, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-904.
148. Bitter T, Prinz CN, Faber L, et a l. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail. 2009;11:602-8.
149. Bitter T, Westerheide N, Faber L, et a l. Adaptive seroventilation in diastolic heart failure and cheyne-stokes respiration. Eur Respir J. 2010;36:385-92.
150. Anand IS. Heart failure and anemia: Mechanisms and pathophysiology. Heart Fail Rev. 2008;13:379-86.
151. Silverberg DS, Wexler D, Iaina A, Schwartz D. Anemia, chronic renal disease and chronic heart failure: Th e Cardio Renal Anemia Syndrome: Th e need for cooperation between cardiologists and nephrologists. Int Urol Nephrol. 2006;38:295- 310. (Pubitemid 44138158)
152. Malyszko J, Zbroch E, Malyszko J, et al. Th e cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patients. Arch Med Sci. 2010;6:539- 44.
153. Felker GM, Shah LK, Stough WG, et al. Anemia in patients with heart failure and preserved systolic function. Am Heart J. 2006; 151:45-62.
154. Tehrani F, Phan A, Morrisey R, et al. Prognostic value of anemia in patients with diastolic heart failure. Tex Heart Inst J. 2009;36:220-5.
155. Shamagian LG, Roman AV, Garcia-Acuna JM, et a l. Anemia is associated with higher mortality among patients with heart failure with preserved systolic function. Heart. 2006;92:780-4. (Pubitemid 43799211)
156. von Haehling S, van Veldhuisen DJ, Roughton M, et al. Anemia among patients with heart failure and preserved or reduced ejection fraction: Results from the SENIORS study. Eur J Heart Fail. 2011;13:656-63.
157. Parissis JT, Kourea K, Panou F, et a l. Eff ects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am Heart J. 2008;155:751.e1- 7.
158. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-13. (Pubitemid 34815352)
159. Abdel-Aziz TA, Mohamed RH, Pasha HF. Leptin, leptin gene and leptin receptor gene polymorphism in heart failure with preserved ejection fraction. Heart Vessels. 2011 May 17. [Epub ahead of print].
160. Kapoor JR, Heinden Reich PA. Obesity and survival in patients with heart failure and preserved systolic function: A U-shaped relationship. Am Heart J. 2010;159:75-80.
161. Haass M, Kitzman DW, Anand IS, et al. Body mass index and adverse cardiovascular outcomes in heart failure with preserved ejection fraction: results from the Irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4:305-13.
162. Chobanian AV, Bakris GL, Black HR, et a l. Th e Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003; 289:2560-72. (Pubitemid 37430158)
163. Baker DW. Prevention of heart failure. J Card Fail. 2002;8:333- 4 6. (Pubitemid 35253205)
164. Haider AW, Larson MC, Franklin SS, Levy D. Systolic blood pressure, diastolic blood pressure and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2003;138:10- 16. (Pubitemid 36232089)
165. Lee DS, Vasan SR. Goals and guidelines for treating hypertension in a patient with heart failure. Curr Treat Options Cardiovasc Med. 2006;8:334-44. (Pubitemid 44101330)
166. Wang Y, Wang QJ. Th e prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines: New challenges of the old problem. Arch Intern Med. 2004;163:2126-34. (Pubitemid 39410802)
167. Julius S, Nesbitt SD, Egan BM, et a l. Feasibility of treating hypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354: 1685-97.
168. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fi brosis in patients with hypertensive heart disease. Circulation. 2000;102:1388-93.
169. Grandi AM, Imperiale D, Santillo R, et al. Aldosterone antagonist improves diastolic function in essential hypertension. Hypertension. 2002;40:647-52. (Pubitemid 35278600)
170. Depre C, Rider MH, Hue L. Mechanism of control of heart glycolysis. Eur J Biochem. 1998;258:277-90.
171. Morgan HE. Fueling the heart. Circ Res. 2003;92:1276-8. (Pubitemid 36773466)
172. Abel ED. Myocardial insulin resistance and cardiac complications of diabetes. Immune Endocr Metabol Disord. 2005;5:219-26. (Pubitemid 40766868)
173. Grossman W, Mann JT. Evidence for impaired left ventricular relaxation in man. Eur J Cardiol. 1978;7(suppl):239-45.
174. Bourdillon PD, Loreel BH, Mirsky I, et al. Increased regional myocardial stiff ness of the left ventricle during pacing-induced angina in man. Circulation. 1983;67:316- 23. (Pubitemid 13172569)
175. Stone HP, Chaitman BR, Stocke K, et a l. Th e anti-ischemic action of Ranolazine in stable ischemic heart disease. J Am Coll Cardiol. 2010;56:934-42.
176. Hayashida W, Vaneyll C, Rousseau MF, Pouleur H. Eff ects of Ranolazine on left ventricular diastolic function in patients with ischemic heart disease. Cardiovasc Drugs Th er. 1994;8:741- 7. (Pubitemid 24376754)
177. Fragosso G, Palloshi A, Puchett P, et a l. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol. 2006;48:992-8. (Pubitemid 44292461)
178. Schwarz ER, Dashti R. Th e clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure. Cardiovas J Afr. 2010;21:212-40.
179. Shibata S, Hastings JL, Prasad 180. A, et a l. Congestive heart failure with preserved ejection fraction is associated with severely impaired dynamic Starling mechanism. J Appl Physiol. 2011;110: 964-71.
180. Mottram PM, Haluska B, Leano R, et a l. Eff ect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation. 2004;110:558-65. (Pubitemid 39031173)
181. Clements IP. Spectrum of systolic and diastolic dysfunction in the presence of normal left ventricular ejection fraction. J Cardiac Fail. 2003;9:S24-6.
182. Yu CM, Zhang Q, Yip GW, et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: A common but ignored condition. J Am Coll Cardiol. 2007;49:97-105. (Pubitemid 46039794)
183. Wang YC, Hwang JJ, Lai LP, et al. Coexistence and exercise exacerbation of intra-left ventricular contractile dyssynchrony in hypertensive patients with diastolic heart failure. Am Heart J. 2007;154: 278-84.
184. Schuster I, Habib G, Jego C, et a l. Diastolic asynchrony is more frequent than systolic asynchrony in dilated cardiomyopathy and is less improved by cardiac resynchronization therapy. J Am Coll Cardiol. 2005;46:2250-7. (Pubitemid 41785493)
185. Schuler BT, Leon AR. Cardiac resynchronization therapy. Curr Cardiol Rep. 2005;7:321- 8. (Pubitemid 41419346)
186. Shanks M, Bertini M, Delgado V, et a l. Eff ect of biventricular pacing on diastolic dyssynchrony. J Am Coll Cardiol. 2010;56:1567-75.